ITGB2 and neoplasm: The interaction between neutrophils and antibody-opsonized tumor cells was further strengthened after pre-incubation of neutrophils with the SIGLEC-5/14 blocking antibody, while this was completely abrogated by the addition of a blocking antibody against CD18 (Figure 4d,e).